Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kluft

Showing results (161-170 of 230) with videos related to

Pageof 23
Sort By:
Thrombosis and Haemostasis|December 1, 1995
An amino acid polymorphism in histidine-rich glycoprotein (HRG) explains 59% of the variance in plasma HRG levelsB C Hennis, D I Boomsma, P A van Boheemen, et al.
Thrombosis and Haemostasis|September 29, 1989
Quantitation of plasma levels of tetranectin--effects of oral contraceptives, pregnancy, treatment with L-asparaginase and liver cirrhosisC Kluft, P Los, I Clemmensen, et al.
Blood|March 1, 1986
The mutual relationship between the two molecular forms of the major fibrinolysis inhibitor alpha-2-antiplasmin in bloodC Kluft, P Los, A F Jie, et al.
Science (New York, N.Y.)|October 9, 1987
Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activityW E Holmes, H R Lijnen, L Nelles, et al.
Thrombosis and Haemostasis|May 11, 1999
DNA-polymorphisms and plasma levels of vascular disease risk factors in Greenland Inuit--is there a relation with the low risk of cardiovascular disease in the Inuit?M P de Maat, E M Bladbjerg, L G Johansen, et al.
European Journal of Clinical Nutrition|July 31, 2001
Fruit and vegetables and cardiovascular risk profile: a diet controlled intervention studyW M Broekmans, W A Klöpping-Ketelaars, C Kluft, et al.
Thrombosis and Haemostasis|March 15, 2001
Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial diseaseJ G van der Bom, M L Bots, F Haverkate, et al.
Clinical Pharmacology and Therapeutics|September 1, 1991
The pharmacokinetics of recombinant double-chain t-PA (duteplase): effects of bolus injection, infusions, and administration by weight in patients with myocardial infarctionR W Koster, A F Cohen, C Kluft, et al.
European Journal of Clinical Pharmacology|April 7, 1999
The oral bioavailability of pentosan polysulphate sodium in healthy volunteersR A Faaij, N Srivastava, J M van Griensven, et al.
Thrombosis and Haemostasis|October 6, 1997
Seasonal variation in fibrinogen in the Rotterdam StudyJ G van der Bom, M P de Maat, M L Bots, et al.
Pageof 23

Showing results (161-170 of 230) with videos related to

Sort By:
Pageof 23
Thrombosis and Haemostasis|December 1, 1995
An amino acid polymorphism in histidine-rich glycoprotein (HRG) explains 59% of the variance in plasma HRG levelsB C Hennis, D I Boomsma, P A van Boheemen, et al.
Thrombosis and Haemostasis|September 29, 1989
Quantitation of plasma levels of tetranectin--effects of oral contraceptives, pregnancy, treatment with L-asparaginase and liver cirrhosisC Kluft, P Los, I Clemmensen, et al.
Blood|March 1, 1986
The mutual relationship between the two molecular forms of the major fibrinolysis inhibitor alpha-2-antiplasmin in bloodC Kluft, P Los, A F Jie, et al.
Science (New York, N.Y.)|October 9, 1987
Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activityW E Holmes, H R Lijnen, L Nelles, et al.
Thrombosis and Haemostasis|May 11, 1999
DNA-polymorphisms and plasma levels of vascular disease risk factors in Greenland Inuit--is there a relation with the low risk of cardiovascular disease in the Inuit?M P de Maat, E M Bladbjerg, L G Johansen, et al.
European Journal of Clinical Nutrition|July 31, 2001
Fruit and vegetables and cardiovascular risk profile: a diet controlled intervention studyW M Broekmans, W A Klöpping-Ketelaars, C Kluft, et al.
Thrombosis and Haemostasis|March 15, 2001
Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial diseaseJ G van der Bom, M L Bots, F Haverkate, et al.
Clinical Pharmacology and Therapeutics|September 1, 1991
The pharmacokinetics of recombinant double-chain t-PA (duteplase): effects of bolus injection, infusions, and administration by weight in patients with myocardial infarctionR W Koster, A F Cohen, C Kluft, et al.
European Journal of Clinical Pharmacology|April 7, 1999
The oral bioavailability of pentosan polysulphate sodium in healthy volunteersR A Faaij, N Srivastava, J M van Griensven, et al.
Thrombosis and Haemostasis|October 6, 1997
Seasonal variation in fibrinogen in the Rotterdam StudyJ G van der Bom, M P de Maat, M L Bots, et al.
Pageof 23